Contact this trialFirst, we need to learn more about you.
MAPK Pathway Inhibitor
DCC-3084 for Cancer
Recruiting1 awardPhase 1 & 2
Los Angeles, California
This trial is testing a new drug called DCC-3084 on its own or with other cancer treatments in people with advanced cancers. It will first focus on patients with solid tumors and may include other
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.